VMI
BLPH

VHCP Management III’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

VHCP Management III’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$134K Sell
25,597
-135,551
-84% -$862K 0.03% 18
2019
Q3 		$1.17M Hold
161,148
– – 0.72% 13
2019
Q2 		$1.45M Hold
161,148
– – 0.68% 13
2019
Q1 		$1.58M Buy
161,148
+9,523
+6% +$105K 0.92% 13
2018
Q4 		$1.82M Hold
151,625
– – 1.33% 13
2018
Q3 		$2.46M Buy
+151,625
New +$3.6M 1.86% 9

Other funds holding BLPH

NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VHCP Management III's BLPH Position: Q4 2019 in Review

VHCP Management III reduced its Bellerophon Therapeutics, Inc. (BLPH) stake by 84% in Q4 2019, selling an estimated $862K and leaving 25,597 shares worth $134K. The position accounts for 0.03% of the portfolio, ranked #18.

VHCP Management III first reported a position in BLPH in Q3 2018 and has held it in 6 quarters since. The position peaked at $2.46M in Q3 2018. 19 funds tracked by Wall St. Rank hold BLPH as of Q4 2019.

  • VHCP Management III held 25,597 shares of Bellerophon Therapeutics, Inc. worth $134K as of Q4 2019.
  • VHCP Management III sold 135,551 Bellerophon Therapeutics, Inc. shares in Q4 2019, an estimated $862K.
  • Bellerophon Therapeutics, Inc. made up 0.03% of VHCP Management III's portfolio in Q4 2019, its #18 holding.
  • VHCP Management III first reported a position in Bellerophon Therapeutics, Inc. in Q3 2018 and has held it in 6 quarters since.
  • VHCP Management III's Bellerophon Therapeutics, Inc. position peaked at $2.46M in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.